Evolent Health Shares Outstanding 2014-2026 | EVH
Evolent Health shares outstanding from 2014 to 2026. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
|
Evolent Health Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2025 | 114 |
| 2024 | 115 |
| 2023 | 111 |
| 2022 | 94 |
| 2021 | 86 |
| 2020 | 85 |
| 2019 | 82 |
| 2018 | 77 |
| 2017 | 64 |
| 2016 | 45 |
| 2015 | 46 |
| 2014 | 2 |
| 2013 | 3 |
|
Evolent Health Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2026-06-30 | 113 |
| 2026-03-31 | 112 |
| 2025-12-31 | 114 |
| 2025-09-30 | 114 |
| 2025-06-30 | 116 |
| 2025-03-31 | 115 |
| 2024-12-31 | 115 |
| 2024-09-30 | 115 |
| 2024-06-30 | 115 |
| 2024-03-31 | 114 |
| 2023-12-31 | 111 |
| 2023-09-30 | 112 |
| 2023-06-30 | 111 |
| 2023-03-31 | 108 |
| 2022-12-31 | 94 |
| 2022-09-30 | 99 |
| 2022-06-30 | 90 |
| 2022-03-31 | 90 |
| 2021-12-31 | 86 |
| 2021-09-30 | 86 |
| 2021-06-30 | 85 |
| 2021-03-31 | 85 |
| 2020-12-31 | 85 |
| 2020-09-30 | 85 |
| 2020-06-30 | 85 |
| 2020-03-31 | 85 |
| 2019-12-31 | 82 |
| 2019-09-30 | 84 |
| 2019-06-30 | 82 |
| 2019-03-31 | 79 |
| 2018-12-31 | 77 |
| 2018-09-30 | 78 |
| 2018-06-30 | 77 |
| 2018-03-31 | 75 |
| 2017-12-31 | 64 |
| 2017-09-30 | 70 |
| 2017-06-30 | 59 |
| 2017-03-31 | 53 |
| 2016-12-31 | 45 |
| 2016-09-30 | 43 |
| 2016-06-30 | 43 |
| 2016-03-31 | 42 |
| 2015-12-31 | 46 |
| 2015-09-30 | 41 |
| 2015-06-30 | 37 |
| 2015-03-31 | 3 |
| 2014-12-31 | 2 |
| 2014-09-30 | 3 |
| 2014-06-30 | 2 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.423B | $1.876B |
| Evolent Health, Inc. is involved in the healthcare delivery and payment markets. The company provides technology-enabled services platform for providers to transition their organization in value-based payment models. Evolent Health, Inc. is based in Arlington, Virginia. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $42.890B | 42.79 |
| Tempus AI (TEM) | United States | $12.625B | 0.00 |
| 10x Genomics (TXG) | United States | $9.470B | 0.00 |
| Hinge Health (HNGE) | United States | $7.563B | 72.66 |
| Hims & Hers Health (HIMS) | United States | $6.533B | 0.00 |
| Doximity (DOCS) | United States | $4.624B | 28.50 |
| Heartflow (HTFL) | United States | $4.200B | 0.00 |
| IRhythm Holdings (IRTC) | United States | $3.686B | 243.09 |
| Privia Health (PRVA) | United States | $2.602B | 97.00 |
| Clover Health Investments (CLOV) | United States | $2.422B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.103B | 32.05 |
| Butterfly Network (BFLY) | United States | $1.933B | 0.00 |
| Schrodinger (SDGR) | United States | $1.767B | 0.00 |
| Omnicell (OMCL) | United States | $1.475B | 21.06 |
| Azenta (AZTA) | United States | $1.455B | 79.07 |
| Enovis (ENOV) | United States | $1.076B | 5.57 |
| Talkspace (TALK) | United States | $0.879B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.669B | 0.00 |
| Phreesia (PHR) | United States | $0.636B | 34.13 |
| Veradigm (MDRX) | United States | $0.597B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.595B | 0.00 |
| Claritev (CTEV) | United States | $0.569B | 0.00 |
| Carlsmed (CARL) | United States | $0.418B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.379B | 0.00 |
| CapsoVision (CV) | United States | $0.300B | 0.00 |
| Standard BioTools (LAB) | United States | $0.278B | 0.00 |
| American Well (AMWL) | United States | $0.221B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.147B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.130B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.117B | 0.00 |
| CareCloud (CCLD) | United States | $0.089B | 6.53 |
| Pulmonx (LUNG) | United States | $0.084B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.063B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.060B | 0.00 |
| Outset Medical (OM) | United States | $0.059B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.055B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.050B | 0.00 |
| Precipio (PRPO) | United States | $0.048B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.034B | 0.00 |
| 111 (YI) | China | $0.030B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.025B | 0.00 |
| HeartBeam (BEAT) | United States | $0.023B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| DataMeds AI (MEDS) | United States | $0.019B | 0.00 |
| HeartSciences (HSCS) | United States | $0.018B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.010B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.010B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.008B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.005B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |
| PROFUSA (PFSA) | United States | $0.001B | 0.00 |
| Zhongchao (ZCMD) | China | $0.001B | 0.00 |
| TruBridge (TBRG) | United States | $0.000B | 0.00 |